RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$880M
AUM Growth
-$133M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
96
New
Increased
Reduced
Closed

Top Buys

1
+$8.69M
2
+$8.01M
3
+$7.72M
4
TMO icon
Thermo Fisher Scientific
TMO
+$7.25M
5
RPRX icon
Royalty Pharma
RPRX
+$6.31M

Top Sells

1
+$16.1M
2
+$15.7M
3
+$10.9M
4
MCK icon
McKesson
MCK
+$10.4M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.57M

Sector Composition

1 Healthcare 98.45%
2 Industrials 0.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$29.3M 3.32%
111,000
-1,000
2
$29.2M 3.32%
90,000
-33,500
3
$29.1M 3.31%
190,000
-5,000
4
$28.8M 3.27%
56,000
-2,000
5
$28.3M 3.22%
540,000
+17,500
6
$27.5M 3.13%
57,000
+10,801
7
$27M 3.07%
725,000
+215,000
8
$26.9M 3.05%
290,000
+55,000
9
$26.8M 3.04%
95,000
+5,500
10
$25.9M 2.95%
325,299
-10,538
11
$25M 2.84%
160,000
-21,976
12
$24.2M 2.75%
265,000
+40,000
13
$20.6M 2.33%
63,000
-32,000
14
$20.2M 2.29%
37,100
+13,350
15
$20.1M 2.29%
43,000
+16,500
16
$18.5M 2.1%
170,000
+80,000
17
$18.1M 2.05%
73,000
+5,000
18
$17.8M 2.02%
100,000
-13,000
19
$17.7M 2.01%
125,000
+17,000
20
$14.1M 1.6%
70,000
+17,500
21
$13.7M 1.56%
261,000
+58,000
22
$13.7M 1.56%
60,912
+22,560
23
$13.6M 1.55%
240,000
24
$13.6M 1.54%
70,978
+16,178
25
$13.5M 1.53%
150,000
-10,000
1
2 3 4